These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3907541)

  • 21. [Value of the immune response in assessing the efficacy of an antimalarial treatment].
    Marinov R; Teodorescu C; Sandu M; Brezuleanu S
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):313-7. PubMed ID: 3317691
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels.
    Carvalho LJ; Oliveira SG; Theisen M; Alves FA; Andrade MC; Zanini GM; Brígido MC; Oeuvray C; Póvoa MM; Muniz JA; Druilhe P; Daniel-Ribeiro CT
    Scand J Immunol; 2004 Apr; 59(4):363-72. PubMed ID: 15049780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific proliferative response of human lymphocytes to purified soluble antigens from Plasmodium falciparum in vitro cultures and to antigens from malaria patients' sera.
    Bygbjerg IC; Jepsen S; Theander TG; Odum N
    Clin Exp Immunol; 1985 Feb; 59(2):421-6. PubMed ID: 3884198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunologic prevention of malaria].
    Wagner WH
    Med Monatsschr Pharm; 1990 Jul; 13(7):209-15. PubMed ID: 1695990
    [No Abstract]   [Full Text] [Related]  

  • 25. Merozoite selection of erythrocytes by age and the induction of protective immunity.
    Brown KN; Carlsson J; Jarra W
    Blood Cells; 1990; 16(2-3):313-8. PubMed ID: 2096982
    [No Abstract]   [Full Text] [Related]  

  • 26. Defined Plasmodium falciparum antigens in malaria serology.
    Gabra MS; Grossiord D; Perrin LH; Shaw A; Cheung A; McGregor IA
    Bull World Health Organ; 1986; 64(6):889-96. PubMed ID: 3549031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria.
    Hviid L; Salanti A
    Parasitology; 2007; 134(Pt 13):1871-6. PubMed ID: 17958922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte response to purified Plasmodium falciparum antigens during and after malaria.
    Bygbjerg IC; Jepsen S; Theander TG
    Acta Trop; 1986 Mar; 43(1):55-62. PubMed ID: 2872787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
    N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current state of the studies of malaria vaccine].
    Dzbeński TH
    Przegl Epidemiol; 1990; 44(3):173-8. PubMed ID: 2084799
    [No Abstract]   [Full Text] [Related]  

  • 32. [New prospects for the epidemiologic and immunologic study of malaria by the Western blotting technic].
    Thelu J; Ambroise-Thomas P
    C R Acad Sci III; 1988; 306(1):11-6. PubMed ID: 3126981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host responsiveness to malaria epitopes and immunopathology.
    Del Giudice G; Grau GE; Lambert PH
    Prog Allergy; 1988; 41():288-330. PubMed ID: 2457218
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasmodium falciparum: natural and experimental transmission-blocking immunity.
    Targett GA
    Immunol Lett; 1988 Nov; 19(3):235-40. PubMed ID: 3069711
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of asexual blood stage malaria vaccines.
    Kidson C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):391-6. PubMed ID: 3064322
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasmodium falciparum: immune pressure in Saimiri sciureus monkeys can select for a parasite population inducing a protective immunity that is not controlled by antibody.
    Morales-Betoulle ME; de la Salmonière YO; Zwetyenga J; Le Scanf C; Jouin H; Michel JC
    Exp Parasitol; 1998 Sep; 90(1):49-57. PubMed ID: 9709030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New candidate vaccine neutralizes all tested strains of malaria parasite.
    Hum Vaccin Immunother; 2012 Feb; 8(2):153-4. PubMed ID: 22745944
    [No Abstract]   [Full Text] [Related]  

  • 38. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human antibody response against the major merozoite surface antigen of P. falciparum is mainly directed against non-conserved sequences.
    Müller HM; Früh K; Doumbo O; Lyon JA; Bujard H
    Behring Inst Mitt; 1991 Feb; (88):157-60. PubMed ID: 2049033
    [No Abstract]   [Full Text] [Related]  

  • 40. [Application of ELISA for the detection of malaria antibody].
    Li XZ; Jin SX; Yang PF; Yu WX
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1985; 3(4):272-5. PubMed ID: 3915731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.